Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant chemotherapy in locally advanced colon cancer
IRCT20130819014404N2Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Nov 2018
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of oxaliplatin, fluorouracil, folinic acid and capecitabine in colon cancer (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoints: Disease-free survival, Histological response after surgery and 1 more. Started Nov 2018; status: completed.
02
Drugs
oxaliplatinfluorouracilfolinic acidcapecitabine
03
Conditions
colon cancer
Beyond the preview
Go deeper on IRCT20130819014404N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130819014404N2.